Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04465890 |
|---|---|
| Brief Title: | A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients |
| First Submitted : | June 22, 2020 |
| First Submitted that Met QC Criteria : | July 9, 2020 |
| First Posted : | July 10, 2020 |
| Last Update Submitted that Met QC Criteria : | April 2, 2024 |
| Last Update Posted : | April 3, 2024 |